GlassScriptPhysician profile
Christopher C Rigsby
NPI 1619111523
$2,130.04
in general payments reported to CMS, 2019-2025
5 companies · $1,761 in 2025
The $1,761 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $147 · 2023: $78.76 · 2024: $36.46 · 2025: $1,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,129 · Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,129.12 |
| Food and Beverage | $746.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,626.36 | 2025 | Hemosphere |
| Edwards Lifesciences Corporation | $166.21 | 2020-2023 | Hemosphere |
| Pacira Pharmaceuticals Incorporated | $143.62 | 2019-2024 | Exparel |
| La Jolla Pharmaceutical Company | $134.16 | 2025 | Giapreza |
| Abiomed | $59.69 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rigsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.